---
schema_version: "secwatch.filing_event.v1"
accession: "0001872789-23-000029"
form_type: "8-K"
ticker: "EMBC"
cik: "0001872789"
company_name: "Embecta Corp."
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T22:54:01.062515+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Embecta Q4 revenue $281.9M (+2.7%); guides FY2024 revenue down 1-3%

## Summary
- Q4 GAAP EPS $0.10, adjusted EPS $0.59; full-year adjusted EPS $2.99.
- FY2024 revenue guidance $1,085-1,105M (reported -3% to -1%); adj. EPS $1.90-$2.10.
- Dividend declared $0.15/share, payable Dec 15, 2023, record Dec 4.
- Added as exclusive/dual-preferred brand with three top Medicare Part D payers starting Jan 2024.
- Type 2 closed loop insulin pump development on track with FDA Breakthrough Device Designation.

## SEC filing metadata
- accession: 0001872789-23-000029
- form_type: 8-K
- ticker: EMBC
- cik: 0001872789
- company_name: Embecta Corp.
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1872789/000187278923000029/0001872789-23-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1872789/000187278923000029/embc-20231121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001872789-23-000029
- JSON: https://secwatch.observer/filing/0001872789-23-000029.json
- Plain text: https://secwatch.observer/filing/0001872789-23-000029.txt

## Key facts
- Earnings Releases
  Embecta Corp. updated its the quarter and fiscal year ended September 30, 2023 guidance (initiated).
  - Period: the quarter and fiscal year ended September 30, 2023
  - Guidance: initiated
  - Result: reported results
  source text: Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1872789/000187278923000029/0001872789-23-000029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.